1. Home
  2. NTZ vs MDCX Comparison

NTZ vs MDCX Comparison

Compare NTZ & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTZ
  • MDCX
  • Stock Information
  • Founded
  • NTZ 1959
  • MDCX 2008
  • Country
  • NTZ Italy
  • MDCX United States
  • Employees
  • NTZ N/A
  • MDCX N/A
  • Industry
  • NTZ Home Furnishings
  • MDCX
  • Sector
  • NTZ Consumer Discretionary
  • MDCX
  • Exchange
  • NTZ Nasdaq
  • MDCX Nasdaq
  • Market Cap
  • NTZ 37.2M
  • MDCX 36.2M
  • IPO Year
  • NTZ 1993
  • MDCX N/A
  • Fundamental
  • Price
  • NTZ $2.80
  • MDCX $2.39
  • Analyst Decision
  • NTZ
  • MDCX Strong Buy
  • Analyst Count
  • NTZ 0
  • MDCX 2
  • Target Price
  • NTZ N/A
  • MDCX $23.50
  • AVG Volume (30 Days)
  • NTZ 2.1K
  • MDCX 412.8K
  • Earning Date
  • NTZ 04-13-2023
  • MDCX 11-22-2025
  • Dividend Yield
  • NTZ N/A
  • MDCX N/A
  • EPS Growth
  • NTZ N/A
  • MDCX N/A
  • EPS
  • NTZ N/A
  • MDCX N/A
  • Revenue
  • NTZ $337,653,480.00
  • MDCX N/A
  • Revenue This Year
  • NTZ N/A
  • MDCX N/A
  • Revenue Next Year
  • NTZ N/A
  • MDCX N/A
  • P/E Ratio
  • NTZ N/A
  • MDCX N/A
  • Revenue Growth
  • NTZ N/A
  • MDCX N/A
  • 52 Week Low
  • NTZ $2.15
  • MDCX $1.79
  • 52 Week High
  • NTZ $6.27
  • MDCX $8.94
  • Technical
  • Relative Strength Index (RSI)
  • NTZ 37.44
  • MDCX 48.03
  • Support Level
  • NTZ $3.05
  • MDCX $2.18
  • Resistance Level
  • NTZ $3.40
  • MDCX $2.62
  • Average True Range (ATR)
  • NTZ 0.11
  • MDCX 0.24
  • MACD
  • NTZ -0.08
  • MDCX -0.02
  • Stochastic Oscillator
  • NTZ 0.00
  • MDCX 18.39

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

Share on Social Networks: